Compliance & Validation — Documented
ISO 27001, SOC 2 Type II
Risk-based quality management (RBQM) platform for clinical trials with AI-augmented central monitoring.
Cyntegrity, founded in 2013 and headquartered in Frankfurt, Germany, provides the EarlyBird risk-based quality management platform for clinical trials, covering risk assessment, key risk indicators and central statistical monitoring. Its compliance pages document an ISO 27001:2022 certification and SOC 2 examinations, plus an ISO 9001:2015 certification that sits outside this directory's filter set. The company is privately held.
64% — Partial coverage. Coverage score — how completely Atlas documents Cyntegrity across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
ISO 27001, SOC 2 Type II
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, CRO / CDMO, Clinical Operations, Data Management
Clinical Data Management
Private, Founded 2013
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?